why is serena williams on glp 1 Inside Williams' partnership with Ro for GLP-1s Serena Williams is opening up

GLP-Squared starts at $249 per month with pricing that remains flat regardless of dose escalation, allowing patients to optimize their metabolic response without escalating out-of-pocket costs

Sepsis emerged as the most common cause of AKI in this study, accounting for 55.2% of cases, followed by cardiorenal syndrome at 34.2% (Table S1 )

While hypotheses about the potential mental health impacts of GLP-1s are still new, a few exciting clinical trials are already trying to get answers

Statistical analysis Data are presented as mean (standard deviation, SD) for continuous variables, or as percentage for categorical variables

The efficacy difference is substantial